Implementing quality assurance (QA) scheme

Summary

1.Situational analysis of quality management system implementation in EU population-based cancer screening programmes, which entails a stakeholder survey to identify EU population-based screening programmes, assessment of the extent of quality management system implementation, and determining number of countries with certification.
2. Identifying necessary resources for QA system implementation in established cancer screening programmes, which entails interviews with stakeholders involved in certified population-based screening programmes to delineate the required resources.
3. Identifying steps necessary for implementing PROMs in cancer screening programmes, which entails a systematic review to understand the nuances and challenges of integrating PROMS into cancer screening units, and a survey of EU MS that have successfully implemented them. We will also develop a robust and adaptable framework for their implementation across EU.
This task will be led by UCY, Cyprus, co-led by ICO, Spain.

Subscribe to our newsletter to get news and updates.

Subscribe to our newsletter to get news and updates.

Logo EU EUCanScreen VerticalThe general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.

tiktok

FaceBook

X

Instagram

YouTube

LinkedIn

EUCanScreenLogo t

The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.

FaceBook

Twitter

Instagram

YouTube

LinkedIn

Logo EU

This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959

Print Friendly, PDF & Email
Μετάβαση στο περιεχόμενο